522 related articles for article (PubMed ID: 18954403)
1. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
Ma XW; Chang ZW; Qin MZ; Sun Y; Huang HL; He Y
Chin Med J (Engl); 2009 Sep; 122(18):2123-8. PubMed ID: 19781296
[TBL] [Abstract][Full Text] [Related]
3. The role of glucocorticoid in SIRP alpha and SHP-1 gene expression in AIHA patients.
de Almeida AC; Barbosa SM; Barjas-Castro Mde L; Olalla-Saad ST; Condino-Neto A
Immunopharmacol Immunotoxicol; 2009; 31(4):636-40. PubMed ID: 19874234
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation.
Khandelwal S; van Rooijen N; Saxena RK
Transfusion; 2007 Sep; 47(9):1725-32. PubMed ID: 17725740
[TBL] [Abstract][Full Text] [Related]
5. IFN-β, IFN-γ, and TNF-α decrease erythrophagocytosis by human monocytes independent of SIRP-α or SHP-1 expression.
de Almeida AC; Barbosa SM; de Lourdes Rios Barjas-Castro M; Olalla-Saad ST; Condino-Neto A
Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):1054-9. PubMed ID: 22738830
[TBL] [Abstract][Full Text] [Related]
6. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
[TBL] [Abstract][Full Text] [Related]
7. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
[TBL] [Abstract][Full Text] [Related]
9. Target cell CD47 regulates macrophage activation and erythrophagocytosis.
Olsson M; Nilsson A; Oldenborg PA
Transfus Clin Biol; 2006; 13(1-2):39-43. PubMed ID: 16564725
[TBL] [Abstract][Full Text] [Related]
10. CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia.
Ahrens N; Pagenkopf C; Kiesewetter H; Salama A
Transfus Med; 2006 Dec; 16(6):397-402. PubMed ID: 17163870
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease.
Al-Faris L; Al-Rukhayes M; Al-Humood S
Hematology; 2017 Mar; 22(2):105-113. PubMed ID: 27667587
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent inhibitory effect of CD47 in macrophage uptake of IgG-opsonized murine erythrocytes.
Olsson M; Nilsson A; Oldenborg PA
Biochem Biophys Res Commun; 2007 Jan; 352(1):193-7. PubMed ID: 17112468
[TBL] [Abstract][Full Text] [Related]
13. Expression of complement regulatory proteins CD55, CD59, CD35, and CD46 in rheumatoid arthritis.
Piccoli AK; Alegretti AP; Schneider L; Lora PS; Xavier RM
Rev Bras Reumatol; 2011; 51(5):503-10. PubMed ID: 21953001
[TBL] [Abstract][Full Text] [Related]
14. Compensation of CD55 Underexpression on Red Blood Cells of β-Thalassemia Major Patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2015; 39(3):184-9. PubMed ID: 25897480
[TBL] [Abstract][Full Text] [Related]
15. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias.
Ruiz-Argüelles A; Llorente L
Autoimmun Rev; 2007 Jan; 6(3):155-61. PubMed ID: 17289551
[TBL] [Abstract][Full Text] [Related]
16. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins.
Ohi H; Tamano M; Sudo S; Okada N
Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235
[TBL] [Abstract][Full Text] [Related]
17. Enhanced phagocytosis of CD47-deficient red blood cells by splenic macrophages requires SHPS-1.
Ishikawa-Sekigami T; Kaneko Y; Saito Y; Murata Y; Okazawa H; Ohnishi H; Oldenborg PA; Nojima Y; Matozaki T
Biochem Biophys Res Commun; 2006 May; 343(4):1197-200. PubMed ID: 16580635
[TBL] [Abstract][Full Text] [Related]
18. Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans.
Amara U; Kalbitz M; Perl M; Flierl MA; Rittirsch D; Weiss M; Schneider M; Gebhard F; Huber-Lang M
Shock; 2010 Jun; 33(6):568-75. PubMed ID: 19864971
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets.
Hernández-Campo PM; Martín-Ayuso M; Almeida J; López A; Orfao A
Cytometry; 2002 Jun; 50(3):191-201. PubMed ID: 12116342
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
